J Cardiovasc Ultrasound.  2010 Sep;18(3):98-100. 10.4250/jcu.2010.18.3.98.

A Case with Upper Extremity Deep Vein Thrombosis after in vitro Fertilization

• Seong SW
• Park JH
• Shin SK
• Jin SA
• Park YK
• Choi SW

• KMID: 2177307
• DOI: http://doi.org/10.4250/jcu.2010.18.3.98

Abstract

Deep vein thrombosis (DVT) is a predisposing condition of pulmonary embolism which can be fatal. Usually, DVT is found in the lower extremities. However, DVT can be occurred in the upper extremities. The usual predisposing conditions of the upper extremity DVT include insertion of central venous catheters and pacemaker wires. Here, we report a case of upper extremity DVT after in vitro fertilization and embryo transfer. The patient was successfully controlled with subcutaneous administration of low molecular weight heparin.

Keyword

Deep vein thrombosis; Upper extremities; in vitro fertilization; Low molecular weight heparin

MeSH Terms

Central Venous Catheters
Embryo Transfer
Fertilization in Vitro
Heparin, Low-Molecular-Weight
Humans
Lower Extremity
Pulmonary Embolism
Upper Extremity
Upper Extremity Deep Vein Thrombosis
Venous Thrombosis
Heparin, Low-Molecular-Weight

Figure

• 

  Fig. 1 The longitudinal image of the right neck shows thrombosis of the right internal jugular vein with partial obstruction of the lumen (A: before compression, B: color flow mapping, and C: after compression). The follow up ultrasound scan reveals normalized internal jugular vein (D: before compression, E: color flow mapping, and F: after compression).

• 

  Fig. 2 The transverse image demonstrates thrombosis of the right internal jugular vein with partial obstruction (A: before compression, and B: after compression). The follow up ultrasound scan shows normalized internal jugular vein (C: before compression, and D: after compression).

Reference

1. Prandoni P, Polistena P, Bernardi E, Cogo A, Casara D, Verlato F, Angelini F, Simioni P, Signorini GP, Benedetti L, Girolami A. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med. 1997. 157:57–62.

2. Bernardi E, Pesavento R, Prandoni P. Upper extremity deep venous thrombosis. Semin Thromb Hemost. 2006. 32:729–736.

3. Mustafa S, Stein PD, Patel KC, Otten TR, Holmes R, Silbergleit A. Upper extremity deep venous thrombosis. Chest. 2003. 123:1953–1956.

4. Chan WS, Ginsberg JS. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost. 2006. 4:1673–1677.

5. Lamon D, Chang CK, Hruska L, Kerlakian G, Smith JM. Superior vena cava thrombosis after in vitro fertilization: case report and review of the literature. Ann Vasc Surg. 2000. 14:283–285.

6. Whelan JG 3rd, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril. 2000. 73:883–896.

7. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001. 119:64S–94S.

8. McRae SJ, Ginsberg JS. Initial treatment of venous thromboembolism. Circulation. 2004. 110:I3–I9.

9. Harrison L, McGinnis J, Crowther M, Ginsberg J, Hirsh J. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med. 1998. 158:2001–2003.

10. Lindhoff-Last E, Nakov R, Misselwitz F, Breddin HK, Bauersachs R. Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin. Br J Haematol. 2002. 118:1137–1142.

11. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 2001. 119:122S–131S.

12. Ginsberg JS, Bates SM. Management of venous thromboembolism during pregnancy. J Thromb Haemost. 2003. 1:1435–1442.